# In the matter of Surya Pharmaceuticals Ltd.

> NCLT judgment dated 2024-05-13. Citation: TCN-2024-NCLT-01362. The case involves a quarterly progress report filed in a liquidation proceeding initiated under…

- **Court:** NCLT
- **Order date:** 13 May 2024
- **Citation:** TCN-2024-NCLT-01362
- **Category:** IBC
- **Source page:** https://caseease.in/cases/ibc/nclt-division-bench-court-i-chenn/surya-pharmaceuticals-ltd-ca03d9f1

## Summary

### Background

The case involves a quarterly progress report filed in a liquidation proceeding initiated under Section 7 of the IBC.

## Facts

The National Company Law Tribunal (NCLT), Principal Bench, New Delhi, heard a matter concerning the liquidation of Surya Pharmaceutical Ltd. The proceeding originated from an order passed under Section 7 of the Insolvency and Bankruptcy Code (IBC). The specific application before the Tribunal was IA-2237/2024, which pertained to a quarterly progress report submitted by the Liquidator.

## Parties

- **Judges:** Ramalingam…; AVINASH K.…
- **Appellants:** State Bank of…
- **Respondents:** Surya Pharmaceutic…
- **Advocates:** For the Petitioner…; For the Respondent…

## Timeline

- **May 13, 2024 — Order Del…**: The NCLT delivered its order regarding the…

## Legal provisions

- [Insolvency and Bankruptcy Code, 2016, Section 7 — Initiation of corporate insolvency resolution…](https://caseease.in/legal-provisions/insolvency-and-bankruptcy-code-2016/section-7)

---

This is a preview. The full structured summary, issues, precedents and source judgment are available on CaseEase - Legal Intelligence Simplified: https://caseease.in/cases/ibc/nclt-division-bench-court-i-chenn/surya-pharmaceuticals-ltd-ca03d9f1
